The latest from OTC Perspectives

Nielsen, Catalina Form Joint Venture to Measure Media Spend

Wednesday, 16 December 2009, 12:44 PM

Nielsen and Catalina announced this week a 50-50 partnership to combine Nielsen's TV ratings and Catalina's purchase data into Nielsen Catalina Ventures.  The new joint-venture, expected to begin selling data in mid-2010, is also expected to "increase efficiency of the package-goods industry's $20 billion in media outlays by at least %10," according to Ad Age.com.

The new company, Nielsen Catalina Ventures, will be led by Mike Nazzaro, formerly CEO of Intelliseek.   Nazzaro said in a statement that he believes this new venture will allow marketers to "realize a significant improvement in marketing effectiveness and efficiency relative to current performance."

Nielsen CEO David Calhoun believes this new partnership "will redefine accountability in the CPG space."  As consumers become more sophisticated and media platforms continue to fragment, advertisers must be able to build more precise and measurable media plans. The only way to get there is with faster, deeper information," said Calhoun in a recent statement. "Nielsen and Catalina’s combined capabilities provide comprehensive, scalable solutions for clients to better shape their marketing investments and measure their campaign ROI with far greater precision, speed and agility."

Related articles

WPP's Sorrell: Slow Growth in 2010 for Ad Industry

Sir Martin Sorrell, chief executive of the advertising group WPP, predicted a slow growth in the upcoming year for the advertising industry during his presentation at

Perrigo Responds to Gluten-Free Trend

The Perrigo Company, a global OTC and generic pharmaceutical company, will launch a labeling program to help consumers identify gluten-free pharmaceutical products

GSK Lights Up New Nicorette Campaign

GSK launched a new $15 million campaign for its OTC nicotine gum Nicorette during primetime TV on December 7th. The campaign, which features the tagline "Quitting

Merck OTC Heartburn Treatment Receives FDA Approval

San Diego-based pharmaceutical company Santarus received regulatory approval Dec. 1 for its OTC heartburn drug Zegerid. The OTC drug, licensed to Schering-Plough Health

Novartis to Launch OTC Prevaid with $200 Million Campaign

Novartis Consumer Health is backing the launch of OTC heartburn medication Prevacid with a $200 million ad campaign, MM&M reports.

Read all related articles


ABOUT SSL CERTIFICATES